UBS Group’s Alpha Tau Medical Warrant DRTSW Stock Holding History

UBS Group’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.81K	Buy	+2,647	New	+$4.41K	﹤0.01%	8736
2026 Q1	–	Sell	-21,360	Closed	-$7.26K	–	10639
2025 Q4	$7.26K	Sell	21,360 -4,260	-17%	-$1.44K	﹤0.01%	8461
2025 Q3	$8.84K	Sell	25,620 -2,769	-10%	-$786	﹤0.01%	8635
2025 Q2	$6.25K	Buy	28,389 +17,813	+168%	+$3.96K	﹤0.01%	9108
2025 Q1	$2.52K	Buy	10,576 +8,093	+326%	+$2.41K	﹤0.01%	9315
2024 Q4	$521	Sell	2,483 -317	-11%	-$65	﹤0.01%	9437
2024 Q3	$532	Buy	2,800 +369	+15%	+$76	﹤0.01%	8907
2024 Q2	$493	Buy	2,431 +2,290	+1,624%	+$543	﹤0.01%	8901
2024 Q1	$35	Buy	+141	New	+$37	﹤0.01%	8966

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

UBS Group's DRTSW Position: Q2 2026 in Review

UBS Group opened a new position in Alpha Tau Medical Warrant (DRTSW) in Q2 2026: 2,647 shares worth $7.81K. The stake represents ﹤0.01% of the portfolio and ranks #8736 among its holdings. This is a return to the name: UBS Group previously reported a position in DRTSW as recently as Q4 2025.

UBS Group first reported a position in DRTSW in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.84K in Q3 2025. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

UBS Group held 2,647 shares of Alpha Tau Medical Warrant worth $7.81K as of Q2 2026.
Alpha Tau Medical Warrant was a new UBS Group position in Q2 2026.
Alpha Tau Medical Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8736 holding.
UBS Group first reported a position in Alpha Tau Medical Warrant in Q1 2024 and has held it in 9 quarters since.
UBS Group's Alpha Tau Medical Warrant position peaked at $8.84K in Q3 2025.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.